In addition, MLF2‐knockdown‐inhibited in vivo xenograft tumor growth was greatly recovered when p53 was concurrently knocked down (Figure 6E–H), suggesting that MLF2 facilitates in vivo colorectal cancer cell growth at least partially via the inhibition of p53. Here, TP53 is linked to colorectal cancer.